RBM42

Across TCGA pan-cancer cohorts, RBM42 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of RBM42’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RBM42 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RBM42 is over-expressed in tumor.

COAD, HNSC, and KIRP are the cancer types where RBM42 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RBM42 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	III,IV	+0.573	<.001	11	view →
HNSC	Male	All	+0.813	<.001	10	view →
KIRP	All	III,IV	+0.607	<.001	10	view →
LIHC	Female	II,III,IV	+1.318	<.001	9	view →
STAD	All	II,III,IV	+0.822	<.001	7	view →
BLCA	All	All	+0.508	.006	6	view →
BRCA	All	All	+0.278	.001	6	view →
CHOL	Female	All	+1.643	<.001	5	view →
LUSC	All	II,III,IV	+0.718	<.001	5	view →
PAAD	All	All	+0.547	.042	4	view →
LUAD	All	III,IV	+0.433	.001	3	view →
KIRC	Female	All	+0.346	.005	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

RBM42–COAD

Open the COAD breakdown →